dc.date.accessioned2022-02-01T21:18:29Z
dc.date.available2022-02-01T21:18:29Z
dc.date.created2022-02-01T21:18:29Z
dc.date.issued2021
dc.identifierhttps://hdl.handle.net/20.500.12866/11326
dc.identifierhttps://doi.org/10.1080/17441692.2021.2001670
dc.description.abstractIn February 2021, the Peruvian 'vaccinegate' scandal broke when the media reported that nearly 500 experimental doses of an ongoing COVID-19 trial were given to key individuals not enrolled in the trial. Indeed, vaccine doses were administered to leading politicians, such as the former President and his wife, and other high-level health officials and academic leaders at the universities overseeing ethical compliance and administration of the trial. The 'vaccinegate' scandal in Peru is but one example of how the lack of a coordinated global response to COVID-19 has allowed countries to act in the best interest of some, ultimately, failing to secure a democratic approach to the right to health for all during a global pandemic. While Peruvian vaccinegate is an example of the egregious use of power to further cronyism amid fear and mounting COVID-19 related death, unfortunately, it is not an anomaly. We argue that the sensationalisation of the event has distracted from the existing precarious health system in Peru and the ways in which long-existing abuses of power evident prior to the pandemic limit a just response to it
dc.languageeng
dc.publisherTaylor and Francis
dc.relationGlobal Public Health
dc.relation1744-1706
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectPeru
dc.subjectvaccine equity
dc.subjectcorruption
dc.subjectglobal health justice
dc.subjectpolitics of COVID-19
dc.titleThe Peruvian COVID-19 vaccine scandal and re-thinking the path to public trust.
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución